Survey of high- and low-level mupirocin-resistant strains of methicillin-resistant Staphylococcus aureus in 15 Japanese hospitals

Chemotherapy

Volumn 49, Issue 1-2, 2003, Pages 36-38

  Fujimura, Shigeru ^a,b   Watanabe, Akira ^b  

^a MIYAGI UNIVERSITY   (Japan)

^b TOHOKU UNIVERSITY   (Japan)

Author keywords

Japan; Low level resistance; Methicillin resistant Staphylococcus aureus; Mupirocin; Surveillance

Indexed keywords

PSEUDOMONIC ACID;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATION; CONTROLLED STUDY; JAPAN; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PREVALENCE; PRIORITY JOURNAL;

ANTI-BACTERIAL AGENTS; CROSS INFECTION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HOSPITALS, GENERAL; HUMANS; JAPAN; METHICILLIN RESISTANCE; MICROBIAL SENSITIVITY TESTS; MUPIROCIN; NASAL CAVITY; PHARYNX; POPULATION SURVEILLANCE; SPUTUM; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; SUPPURATION; URINE;

EID: 0037266063     PISSN: 00093157     EISSN: None     Source Type: Journal    
DOI: 10.1159/000069780     Document Type: Article

References (10)

1. Rahman M, Noble WC, Cookson B: Mupirocin-resistant Staphylococcus aureus. Lancet 1987;ii:387.
2. Cookson BD, Lacey RW, Noble WC, Reeves DS, Wise R, Redhead RJ: Mupirocin-resistant Staphylococcus aureus. Lancet 1990;335:1095-1096.
3. Schmitz FJ, Lindenlauf E, Hofmann B, Fluit AC, Verhoef J, Heinz HP, Jones ME: The prevalence of low- and high-level mupirocin resistance in staphylococci from 19 European hospitals. J Antimicrob Chemother 1998;42:489-495.
4. Cookson B, Farrelly H, Palepou M-F, George R: Mupirocin-resistantStaphylococcus aureus. Lancet 1992;339:625.
5. Miller MA, Dascal A, Portnoy J, Mendelson J: Development of mupirocin resistance among methicillin-resistant Staphylococcus aureus after widespread use of nasal mupirocin ointment. Infect Control Hosp Epidemiol 1996;17:811-813.
6. Slocombe B, Perry C: The antimicrobial activity of mupirocin an update on resistance. J Hosp Infect 1991;19:19-25.
7. Watanabe H, Masaki H, Asoh N, Watanabe K, Oishi K, Furumoto A, Kobayashi S, Sato A, Nagatake T: Low concentrations of mupirocin in the pharynx following intranasal application may contribute to mupirocin resistance in methicillin-resistant Staphylococcus aureus. J Clin Microbiol 2001;39:3775-3777.
8. Marples RR, Speller DC, Cookson BD: Prevalence of mupirocin resistance inStaphylococ-cus aureus.J Hosp Infect 1995;29:153-155.
9. Morgan M, Salmon R, Keppie N, Evans-Williams D, Hosein I, Looker DN: All Wales surveillance of methicillin-resistant Staphylococcus aureus (MRSA): The first year's results. J Hosp Infect 1999;41:173-179.
10. Shimizu K, Shibata Y, Totsuka K, Miyama M, Inamatsu T, Ubukata K, Konno M, Kanno H, Inoue M: The effect of mupirocin nasal ointment for eliminating Staphylococcus aureus including MRSA. Jpn J Environ Infect (in Japanese with English abstract) 1993;8:1-10.